eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
chronic traumatic encephalopathy (cte), a degenerative brain disease, has been linked by medical researchers to the sort of hits football players endure.
.